Article | 12/1/2019

Economic burden of illness associated with localized prostate cancer in the United States

Future Oncology
Gary Gustavsen (Health Advances), Laura Gullett (Health Advances), Doria Cole, Nicolas Lewine and Jay T. Bishoff
Prior studies have established the economic burden of prostate cancer on society. However, changes to screening, novel therapies and increased use of active surveillance (AS) create a need for an updated analysis.
Read here.